Board of Trustees

Our voluntary Board of Trustees meets at least twice a year in addition to our AGM. Members report on finance, strategy, communications, fundraising, scientific meetings and membership. New Trustees are nominated by members and elected by ballot at the charity’s AGM. Trustees are appointed for a minimum of three years.

Interested in becoming a trustee? Find out how here.

David Weinkove

Prof David Weinkove (Chair)

David is an Professor at Durham University. His research focuses on ageing in the nematode worm C. elegans. He discovered mutations in bacteria that slow C. elegans ageing by altering bacterial metabolism. He co-founded Magnitude Biosciences, which provides research services in C. elegans to companies across the world. A BSRA Trustee from 2014-2019, he took up the Chair in 2022.

Dr Paul Morgan (Secretary)

Paul is a Senior Lecturer in Human Nutrition and Metabolism at Manchester Metropolitan University. He has a broad range of interests in physiology, nutrition and metabolism. Broadly speaking, his current primary interests are on the integration of exercise and diet in-vivo across the lifespan, with a predominant focus on protein metabolism and musculoskeletal deterioration in ageing.

View Paul’s trustee profile.

Dr Paul Potter (Treasurer)

Paul is a Reader in Biomedical Sciences at Oxford Brookes University and a Fellow of the Royal Society of Biology. His research focuses on the pathogenesis of chronic and age-related disease, and how to improve modelling of disease. He established and ran the MRC Harwell ageing screen and was a member of the management group of the MouseAGE COST action and the ShARM ageing biobank initiative.

Tina Woods

Founder & CEO, Collider Health; Co-Founder & CEO, Business for Health; Healthy Longevity Champion, National Innovation Centre for Ageing

Niharika Duggal

Dr Niharika A Duggal

Niharika is an assistant professor at the University of Birmingham. Her research group focuses on dissecting host microbiome-immune interactions and investigating the potential of novel microbiome-based therapies to combat immune ageing and improve healthspan in older adults.

Dr Hector Zenil

Hector is Senior Lecturer in Biomedical Engineering at Faculty of Life Science and Medicine at King’s College London, as well as being director and advisor to several company boards in healthcare and fintech in the UK, Canada, and Sweden. He is Founder and Chief Visionary Officer of Oxford Immune Algorithmic, an AI spinout of the University of Oxford.

Dr Jon Houseley

Jon is group leader and head of knowledge exchange and commercialisation at the Babraham Institute. His work studies the mechanisms by which cells adapt to new environments, and the connections between adaptation and ageing.

Ben Raven

Ben is completing his PhD at the University of Sheffield’s Healthy Lifespan Institute, where his research focuses on using extracellular vesicles as a biomarker of senescence.

Dr Sophie Joanisse

Sophie is an assistant professor in Life Sciences at the University of Nottingham. Her research focuses on the mechanisms that lead to skeletal muscle remodelling, with a particular interest on how these mechanisms are impaired in older adults and how they can be improved.

Dr Bradley Elliott

Brad is a Senior Lecturer in Human Physiology and Ageing Biology Group at the University of Westminster. His research interests focus on understanding losses in human muscle and metabolic function with ageing, with particular focus on the endocrine signatures of biological ageing.

View Bradley’s trustee profile.

Dr Ira Milosevic

Ira is an associate professor and laboratory head at the Nuffield Department of Medicine, University of Oxford. She has a broad range of interests in geroscience, human physiology and cell biology. Her research focuses on ‘normal’ human brain ageing as well as the processes that fail in the brain during neurodegeneration. Since 2021, Ira also coordinates a part of collaborative Horizon 2020-funded project at the Multidisciplinary Institute for Ageing in Coimbra, Portugal. A BSRA Trustee since 2022.